Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Calyxt stock | $3.04

Learn how to easily invest in Calyxt stock.

Calyxt Inc is a packaged foods business based in the US. Calyxt shares (CLXT) are listed on the NASDAQ and all prices are listed in US Dollars. Calyxt employs 59 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Calyxt

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CLXT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Calyxt stock price (NASDAQ: CLXT)

Use our graph to track the performance of CLXT stocks over time.

Calyxt shares at a glance

Information last updated 2021-10-16.
Latest market close$3.04
52-week range$2.91 - $12.43
50-day moving average $3.58
200-day moving average $4.24
Wall St. target price$6.83
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.05

Buy Calyxt shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Calyxt stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Calyxt price performance over time

Historical closes compared with the close of $3.04 from 2021-10-19

1 week (2021-10-13) 1.33%
1 month (2021-09-20) -14.85%
3 months (2021-07-20) -25.67%
6 months (2021-04-20) -41.87%
1 year (2020-10-19) -19.15%
2 years (2019-10-18) -38.09%
3 years (2018-10-19) 12.42
5 years (2016-10-16) N/A

Calyxt financials

Revenue TTM $35.4 million
Gross profit TTM $-11,276,000
Return on assets TTM -40.08%
Return on equity TTM -115.22%
Profit margin -106.37%
Book value $0.59
Market capitalisation $109.9 million

TTM: trailing 12 months

Shorting Calyxt shares

There are currently 441,111 Calyxt shares held short by investors – that's known as Calyxt's "short interest". This figure is 8.5% down from 481,905 last month.

There are a few different ways that this level of interest in shorting Calyxt shares can be evaluated.

Calyxt's "short interest ratio" (SIR)

Calyxt's "short interest ratio" (SIR) is the quantity of Calyxt shares currently shorted divided by the average quantity of Calyxt shares traded daily (recently around 130121.23893805). Calyxt's SIR currently stands at 3.39. In other words for every 100,000 Calyxt shares traded daily on the market, roughly 3390 shares are currently held short.

However Calyxt's short interest can also be evaluated against the total number of Calyxt shares, or, against the total number of tradable Calyxt shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Calyxt's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Calyxt shares in existence, roughly 10 shares are currently held short) or 0.0342% of the tradable shares (for every 100,000 tradable Calyxt shares, roughly 34 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Calyxt.

Find out more about how you can short Calyxt stock.

Calyxt share dividends

We're not expecting Calyxt to pay a dividend over the next 12 months.

Calyxt share price volatility

Over the last 12 months, Calyxt's shares have ranged in value from as little as $2.91 up to $12.43. A popular way to gauge a stock's volatility is its "beta".

CLXT.US volatility(beta: 1.89)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Calyxt's is 1.8891. This would suggest that Calyxt's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Calyxt overview

Calyxt, Inc. , a technology company, focuses on delivering plant-based solutions in the United States. It engages in the development of improved digestibility alfalfa; high fiber wheat; high oleic low linolenic soybeans; winter oats; hemp; fat soybeans; and cold storable potatoes. As of March 4, 2021, the company had nine projects at Phase I stage or later in development across alfalfa, hemp, oats, soybeans, and wheat. Calyxt, Inc. has a research collaboration with NRGene, which includes the adoption of NRGene's cloud-based genomics platform to support various research projects; and a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and various geographies outside the United States. The company was formerly known as Cellectis Plant Sciences, Inc.

Frequently asked questions

What percentage of Calyxt is owned by insiders or institutions?
Currently 65.594% of Calyxt shares are held by insiders and 23.121% by institutions.
How many people work for Calyxt?
Latest data suggests 59 work at Calyxt.
When does the fiscal year end for Calyxt?
Calyxt's fiscal year ends in December.
Where is Calyxt based?
Calyxt's address is: 2800 Mount Ridge Road, Roseville, MN, United States, 55113-1127
What is Calyxt's ISIN number?
Calyxt's international securities identification number is: US13173L1070
What is Calyxt's CUSIP number?
Calyxt's Committee on Uniform Securities Identification Procedures number is: 13173L107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site